Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19

David Gómez-Ríos, Víctor A. López-Agudelo, Howard Ramírez-Malule

DOI: 10.7324/JAPS.2020.10501Pages: 001-009

Graphical Abstract

Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19

Manish Dhawan, Manisha Parmar, Khan Sharun, Ruchi Tiwari, Muhammad Bilal, Kuldeep Dhama

DOI: 10.7324/JAPS.2021.110402Pages: 006-013

Graphical Abstract

Immunoinformatics approach in designing SARS-CoV-2 vaccine from experimentally determined SARS-CoV T-cell epitopes

Leana Rich De Mesa Herrera

DOI: 10.7324/JAPS.2021.110303Pages: 029-036

Graphical Abstract

Formulation rationale for the development of SARS-COV-2 immunochromatography rapid test kits in India

Prince Manta, Raveen Chauhan, Himanshu Gandhi, Shikha Mahant, Deepak N. Kapoor

DOI: 10.7324/JAPS.2021.1101017Pages: 128-133

Graphical Abstract

Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review

Manish Dhawan, Kuldeep Dhama, Manisha Parmar, Alisha Sharma, Steffy Angural

DOI: 10.7324/JAPS.2021.1101104Pages: 026–033

Graphical Abstract

Safety, efficacy, and immunogenicity of COVAXIN: A review

Mukhtar Ahmad Dar, Priyadarshani Chauhan, Pawan Kumar, Richa Chauhan, Krishna Murti, Jaykaran Charan, Velayutham Ravichandiran, Sameer Dhingra

DOI: 10.7324/JAPS.2021.1101103Pages: 018-025

Graphical Abstract

Utilization of physical and chemical microbial load reduction agents for SARS-CoV-2: Toxicity and development of drug resistance implications

Sani Yahaya Najib, Yusuf Oloruntoyin Ayipo, Abubakar Shaaban, Mohd Nizam Mordi, Abdullahi Rabiu Abubakar, Adekunle Babajide Rowaiye, Sayeeda Rahman, Rahnuma Ahmad, Bushra Ayat Meghla, Nihad Adnan, Mainul Haque

DOI: 10.7324/JAPS.2021.120101Pages: 001-028

Graphical Abstract

Variations from SARS-CoV-2 to Omicron: A new threat knocking at World’s door

Acharya Balkrishna, Akansha Rohela, Ashwani Kumar, Vedpriya Arya, Nazam Khan

DOI: 10.7324/JAPS.2022.120404Pages: 037-043

Graphical Abstract

In silico prediction of interactions and molecular dynamics simulation analysis of Mpro of Severe Acute Respiratory Syndrome caused by novel coronavirus 2 with the FDA-approved nonprotein antiviral drugs

Subramaniam Sivakumar, Sugumar Mohanasundaram, Narasimhan Rangarajan, Venkatesan Sampath, Maderi Velayutham Dass Prakash

DOI: 10.7324/JAPS.2022.120508Pages: 104-119

Graphical Abstract

Characterization in silico of bioactive compound in tea plant as a potentials inhibitor of SARS-CoV-2 Mpro

Mohamad Endy Yulianto, Ari Yuniastuti, Dadan Rohdiana, Vita Paramita, Hermawan Dwi Ariyanto, Rizka Amalia, Sutrisno Sutrisno, Indah Hartati, Shabri Shabri, Retno Dwi Nyamiati, Siti Rahmawati

DOI: 10.7324/JAPS.2022.120909Pages:

Graphical Abstract

Strong anti-SARS-CoV-2 activity of Lucilia cuprina maggots’ excretion/secretion and its effect on viral entry and notch pathway in vitro: First work

Mohammad R. K. Abdel-Samad, Fatma A. Taher, Mahmoud Shehata, Noura M. Abo Shama, Ahmed Mostafa, Mohamed A. Ali, Iman H. Ibrahim

DOI: 10.7324/JAPS.2022.120713Pages: 122-130

Graphical Abstract

The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq

Ahmed Mohammed Taqi Al Mosawi, Haitham Mahmood Kadhim, Hussam Majeed Hameed

DOI: 10.7324/JAPS.2022.120813Pages: 130-136

Graphical Abstract

Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration

Walid Abu Rayyan

Pages:

Graphical Abstract